Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis Tiago TorresAnne Sohrt PetersenJosé Manuel Carrascosa Original Research Open access 13 April 2024 Pages: 983 - 992
Novel Topical Treatments for Itch Rami H. MahmoudOmar MahmoudGil Yosipovitch Review Open access 13 April 2024 Pages: 829 - 840
Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study Michela StaraceFrancesca PampaloniZoe Apalla Original Research Open access 10 April 2024 Pages: 953 - 970
Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry Eric L. SimpsonBen LockshinAndrew Korotzer Publisher Correction Open access 09 April 2024 Pages: 1367 - 1369
Letter to the Editor Regarding: Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study Ruiyao HuYue WangChen Li Letter Open access 09 April 2024 Pages: 1063 - 1065
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities Luca PotestioNello TommasinoMatteo Megna Review Open access 09 April 2024 Pages: 841 - 852
Response to: Letter to Editor Regarding “Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study” A. David Burden Letter Open access 05 April 2024 Pages: 1067 - 1069
Clinical Characteristics and Therapeutic Aspects of Blaschko Linear Psoriasis Ling ChenYufan ChengZhu Shen Brief Report Open access 05 April 2024 Pages: 1039 - 1048
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis Tina BhutaniJohn KooJ. Gabriel Vasquez Brief Report Open access 04 April 2024 Pages: 1019 - 1025
Acute Systemic Toxicity Caused by Topical Application of EMLA Cream on a Leg Ulcer: Case Report and Review of Literature Sarah Marie HoffmannAnna Luisa HartmannChristoph Mathis Schempp Case Report Open access 03 April 2024 Pages: 1057 - 1062
Utilising SNP Association Analysis as a Prospective Approach for Personalising Androgenetic Alopecia Treatment Manuel Pacareu FrancèsLaura Vila-VecillaGustavo Torres de Souza Original Research Open access 31 March 2024 Pages: 971 - 981
Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis Lawrence F. EichenfieldLinda F. Stein GoldJuliana M. Canosa Original Research Open access 28 March 2024 Pages: 875 - 892
Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study Ying LiChengzhi LvYuling Shi Original Research Open access 27 March 2024 Pages: 907 - 918
Virtual Learning Decreases the Carbon Footprint of Medical Education Divya SharmaJulianne RizzoJenny E. Murase Original Research Open access 26 March 2024 Pages: 853 - 859
Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies April ArmstrongAlvaro González-CanteroAndrew Blauvelt Original Research Open access 23 March 2024 Pages: 933 - 952
Inconsistent Associations Between Risk Factor Profiles and Adjuvant Radiation Therapy (ART) Treatment in Patients with Cutaneous Squamous Cell Carcinoma and Utility of the 40-Gene Expression Profile to Refine ART Guidance Brent R. MoodyAaron S. FarbergWalton A. Taylor Original Research Open access 23 March 2024 Pages: 861 - 873
Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries Sergio Vañó-GalvánAlexander EgebergAnthony Bewley Brief Report Open access 21 March 2024 Pages: 1027 - 1037
Effect of Makeup Use on Depressive Symptoms: An Open, Randomized and Controlled Trial Marcos C. VeçosoSouvenir ZallaVânia R. Leite-Silva Original Research Open access 21 March 2024 Pages: 777 - 791
Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus Luigi GargiuloLuciano IbbaAlessandra Narcisi Original Research Open access 21 March 2024 Pages: 919 - 932
Response Types and Factors Associated with Response Types to Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis from Two Randomized Clinical Trials Alexander EgebergCurdin ConradDiamant Thaçi Original Research Open access 15 March 2024 Pages: 745 - 758
Development and Psychometric Validation of a Patient-Reported Outcome Measure to Assess the Signs and Symptoms of Chronic Hand Eczema: The Hand Eczema Symptom Diary (HESD) Sonja MolinLotte Seiding LarsenMarie L. A. Schuttelaar Original Research Open access 15 March 2024 Pages: 643 - 669
Interleukin-17A Inhibitors in Patients with Psoriasis and Tuberculosis Infection: A 2-Year Prospective Study on Safety Without Preventive Treatment Chun-Xia HeChao WuHong-Zhong Jin Original Research Open access 14 March 2024 Pages: 893 - 906
Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil William J. NahmEvangelos V. BadiavasJohn Shen Case Report Open access 12 March 2024 Pages: 1049 - 1056
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives Lawrence F. EichenfieldJinan LiuPeter Anderson Original Research Open access 08 March 2024 Pages: 685 - 696
Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe Anthony BewleyLauren HiribarneSicily Mburu Original Research Open access 08 March 2024 Pages: 1497 - 1514
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα Julia TittesJennifer BrellJohannes Stöckl Original Research Open access 08 March 2024 Pages: 613 - 626
A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State Tom M. HillaryTine VanhoutvinSéverine Vermeire Original Research Open access 07 March 2024 Pages: 767 - 775
The Need of Differential Diagnosis Between Vulvar Lichen Sclerosus and Autoimmune Dermatoses in Adolescent Girls Agnieszka DulskaJakub BodzionyAgnieszka Drosdzol-Cop Original Research Open access 07 March 2024 Pages: 759 - 766
Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials Rui SunMercedes BustamanteVictor Dong Original Research Open access 07 March 2024 Pages: 729 - 743
The Role of the Gut-Joint Axis in the Care of Psoriatic Arthritis: A Two-Sample Bidirectional Mendelian Randomization Study Yihong GanJingqun LiuYongsheng Fan Original Research Open access 07 March 2024 Pages: 713 - 728
The Real-World Effectiveness and Tolerability of a Soothing Cream Containing the Postbiotic Aquaphilus dolomiae Extract-G2 for Skin Healing Yuling ShiEdward LainAline Stennevin Original Research Open access 07 March 2024 Pages: 697 - 712
Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’” Kim RandJuan Manuel Ramos-GoñiJosé-Carlos Armario-Hita Letter Open access 05 March 2024 Pages: 823 - 827
Successful Treatment of Disseminated Granuloma Annulare with Upadacitinib Axel De GreefGhita BenjellounMarie Baeck Case Report Open access 05 March 2024 Pages: 813 - 817
Treatment Patterns and Negative Health Outcomes in Palmoplantar Pustulosis Patients in Germany and the US Alvan ChengXinqing DengBoni E. Elewski Original Research Open access 05 March 2024 Pages: 627 - 641
Botulinum Toxin A and B for Palmoplantar Hyperhidrosis Trond EilertsenBjørn Øivind KvammenØystein Grimstad Brief Report Open access 01 March 2024 Pages: 805 - 811
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients Ashley WysongAlly‐Khan SomaniSarah T. Arron Original Research Open access 01 March 2024 Pages: 593 - 612
Herpes Zoster Recurrence: A Narrative Review of the Literature Raunak ParikhO’Mareen SpenceIain Kaan Review Open access 28 February 2024 Pages: 569 - 592
Insights into Early Systemic Treatment in Atopic Dermatitis: Scientific Facts and Practical Considerations Efstratios VakirlisStamatios GregoriouEleni Sotiriou Commentary Open access 27 February 2024 Pages: 563 - 568
Readability of Patient Electronic Materials for Atopic Dermatitis in 23 Languages: Analysis and Implications for Dermatologists Tomasz SkrzypczakAnna SkrzypczakJacek C. Szepietowski Original Research Open access 24 February 2024 Pages: 671 - 684
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Valerie J. LudbrookDavid C. BuddWei Jing Loo Original Research Open access 19 February 2024 Pages: 489 - 504
Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab Versus Dupilumab in Moderate-to-Severe Atopic Dermatitis’ Mike BastianNick FreemantlePatricia Guyot Letter Open access 16 February 2024 Pages: 819 - 821
Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence Tina BhutaniAaron S. Farberg Review Open access 16 February 2024 Pages: 341 - 360
Improvements in Plaque Psoriasis Associated with Calcipotriol/Betamethasone Aerosol Foam Treatment: A Post Hoc Analysis of Non-interventional Studies and Clinical Experience Sascha GerdesAnna CampanatiElizabeth Lazaridou Brief Report Open access 15 February 2024 Pages: 793 - 804
Applications of Ultraviolet and Sub-ultraviolet Dermatoscopy in Neoplastic and Non-neoplastic Dermatoses: A Systematic Review Paweł PietkiewiczCristian Navarrete-DechentEnzo Errichetti Review Open access 15 February 2024 Pages: 361 - 390
Efficacy and Safety of Topical Tacrolimus Microemulsion Applied Twice Daily in Patients with Mild to Moderate Scalp Psoriasis Andreas PinterAthanasios Tsianakasfor the ScaTAC study group Original Research Open access 12 February 2024 Pages: 521 - 532
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel Joshua BurshteinMilaan ShahMark Lebwohl Review Open access 10 February 2024 Pages: 323 - 339
Development of a Patient Journey Map for Improving Patient Experience and Quality of Atopic Dermatitis Care Gastón RoustánMarta LoroOlga Isidoro Original Research Open access 09 February 2024 Pages: 505 - 519
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor) Melinda GooderhamRonald VenderLawrence Green Original Research Open access 09 February 2024 Pages: 441 - 451
Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis Hidehisa SaekiYoko KataokaKazuhiko Arima Brief Report Open access 07 February 2024 Pages: 533 - 543
Efficacy and Safety of an Autologous Micrografting Procedure for Management of Striae Distensae in Women Leonor GirãoPedro Pinto Original Research Open access 06 February 2024 Pages: 469 - 488
